COVID update – Tackling booster confusion
Why there is increasingly conflicting booster advice emerging from different parts of the world
Mild cognitive impairment – Personalising care, planning and follow up: Part 4
After the diagnosis of MCI is made, sensitive yet important discussions along the course of progression need to occur
Recommended investigations and diagnostic criteria for osteoporosis
The pros and cons of the various treatments for osteoporosis
Management of pelvic mesh
The ‘red-flags’ which should alert the clinician to the need for early specialist referral
Technology facilitated child sexual abuse – The reality and considerations for clinicians
The importance of ensuring data security in the maintenance of medical records
COVID update – ATAGI’s COVID advice explained
Bivalent COVID-19 vaccine boosters – COVID-19 mAbs and anti-virals
Night-time toilet trips & disrupted sleep
The anticipation of the need to go to the toilet and subsequent disruption of sleep can lead to hypervigilance, anxiety, catastrophising
New vaccine trials, prospects for COVID & future variants
If a new variant is more pathogenic then we are effectively back to square one and yet we have no strategy for this
The management of refractory overactive bladder in women: Part 2
The therapeutic options, medical and surgical, which can be offered to women with refractory overactive bladder, and the pros and cons of each
Mild cognitive impairment – Sharing the diagnosis and following up with your patient: Part 2
When seeing a patient with mild cognitive impairment it is critical for us to know that we are in control, and that we can achieve many positives for the patient’s health
The investigation and management of overactive bladder in women: Part 1
The pros and cons of the various lifestyle and pharmacological management options
COVID-19 boosters: Should we all line up for a 4th or 5th dose?
Dr Gary Grohmann and Prof Robert Booy weigh up the research on boosters
